GSK ends Arzerra patent dispute with Genentech and nonprofit

03/27/2012 | Reuters

Genmab said marketing partner GlaxoSmithKline resolved a patent dispute with Roche Holding unit Genentech and California nonprofit City of Hope concerning Genmab's blood cancer drug Arzerra, or ofatumumab.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY